Patents by Inventor Sarah L. Devos

Sarah L. Devos has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS FOR TREATING AND MONITORING PROGRANULIN-ASSOCIATED DISORDERS
    Publication number: 20260079170
    Abstract: The present disclosure provides methods and materials for screening a compound or monitoring a subject's response to a compound or dosing regimen for treating a PGRN-associated disorder. Methods and materials for identifying and treating a subject having a PGRN-associated disorder are also provided.
    Type: Application
    Filed: September 19, 2025
    Publication date: March 19, 2026
    Applicant: Denali Therapeutics Inc.
    Inventors: Giuseppe Astarita, Sarah L. Devos, Gilbert Di Paolo, Todd P. Logan, Junhua Wang
  • OLIGONUCLEOTIDE CONJUGATES TARGETED TO THE TRANSFERRIN RECEPTOR
    Publication number: 20240299575
    Abstract: Provided herein are conjugates comprising proteins that bind to a transferrin receptor and oligonucleotides that are capable of modulating the expression of a target gene or sequence, as well as methods of use thereof.
    Type: Application
    Filed: July 1, 2022
    Publication date: September 12, 2024
    Inventors: Scarlett Barker, Mark S. Dennis, Sarah L. Devos, Anthony A. Estrada, Mihalis S. Kariolis, Cathal S. Mahon, Lizanne G. Nilewski, Joshua I. Park, Lu Shan, Mai B. Thayer, Raymond Ka Hang Tong, Hai L. Tran, Robert C. Wells, Joy Yu Zuchero
  • METHODS FOR TREATING AND MONITORING FRONTOTEMPORAL DEMENTIA
    Publication number: 20240069041
    Abstract: The present disclosure provides methods and materials for screening a compound or monitoring a subjects response to a compound or dosing regimen for treating frontotemporal dementia (FTD). Methods and materials for identifying and treating a subject having FTD are also provided.
    Type: Application
    Filed: October 13, 2021
    Publication date: February 29, 2024
    Applicant: Denali Therapeutics Inc.
    Inventors: Giuseppe Astarita, Sarah L. Devos, Gilbert Di Paolo, Meng Fang, Fen Huang, Todd P. Logan, Matthew J. Simon
  • METHODS FOR TREATING AND MONITORING PROGRANULIN-ASSOCIATED DISORDERS
    Publication number: 20210396772
    Abstract: The present disclosure provides methods and materials for screening a compound or monitoring a subjects response to a compound or dosing regimen for treating a PGRN-associated disorder. Methods and materials for identifying and treating a subject having a PGRN-associated disorder are also provided.
    Type: Application
    Filed: October 15, 2019
    Publication date: December 23, 2021
    Applicant: Denali Therapeutics Inc.
    Inventors: Giuseppe Astarita, Sarah L. Devos, Gilbert Di Paolo, Todd P. Logan, Junhua Wang